GPR30 is able to bind 17β-estradiol and allows fast nongenomic responses of estrogens such as the stimulation of MAPK pathways, adenylyl cyclase, or c-fos expression in the breast cancer cell line SKBR3 which does not express the classical ERs [127–129]. The gene discussed is GPER1; the disease is breast carcinoma.